Chief Scientific Officer of Summit Therapeutics Inc. (NASDAQ:SMMT), Powell David Jonathan, sells 12,070 shares worth $52,142
According to Summit Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 07:51 PM, company Chief Scientific Officer, Powell David Jonathan disclosed selling 12,070 shares at a cost of $4.32. At the time of this transaction (Nov 25), this trade was worth $52,142 in total. As of Nov 25, Powell David Jonathan now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Summit Therapeutics Inc. (NASDAQ:SMMT) Chief Scientific Officer, Powell David Jonathan, we have the following information:
- SEC Form 4 filing: Nov 23: Sold 6,987 shares at the rate of $4.40 per share. Total worth of this trade was $30,743. Total number of shares owned as of Nov 23 were 0
- SEC Form 4 filing: Nov 24: Sold 11,374 shares at the rate of $4.21 per share. Total worth of this trade was $47,885. Total number of shares owned as of Nov 24 were 0
Posted by
George Daniels
on Thursday November 26 2020, 2:41 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
